Final report of University Hospital Hradec Kralove to the clinical trial protocol no. CAMN107EIC01

Abstract

Realization of a part of clinical trial called Multicenter, open-label phase IIIb evaluation of nilotinib in adult patients with newly diagnosed CML in chronic phase Philadelphia chromosome positive and / or BCR-ABL

Keywords

• nilotinib
• chronic myeloid leukemia